A Study of CC312 for Relapsed/Refractory Autoimmune Diseases

Clinical trial NCT07193810 · RECRUITING

Trial details

NCT number: NCT07193810
Sponsor: CytoCares Inc
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

SLE - Systemic Lupus Erythematosus IIM- Idiopathic Inflammatory Myopathies SSc-Systemic Sclerosis

Start date: 2025-09-23
Primary completion: 2027-09-29
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.